Deproco Report issue

Contributed to NME For profit Phase 4
Founded: Lancaster PA United States (1984)
Status: Defunct (2000)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1984
mepivacaine (carbocaine)
First NDA Approval
2000
articaine (Septocaine)
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DEPROCO

Active Ingredients

Marketed Drugs (9)

Key: Deproco (8) Acquired (1)

articaine (Septocaine) (2000 NDA)

dyclonine (sucrets) (2018)

epinephrine (levophed) (2000)

levobupivacaine (chirocaine) (2006)

levonordefrin (Neo-Cobefrine) (1984)

lidocaine (xylocaine) (1985)

mepivacaine (carbocaine) (1984)

phentolamine mesylate (regitine) (2008)

prilocaine (citanest) (2010)

Drugs in Phase 4 Trials (1)

Key: Deproco (0) Acquired (1)

phentolamine mesylate (regitine) (5 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 5
  • # of Trial APIs: 1